Multiple Sclerosis Report Highlights High Cost of Care in UK
A new report, written jointly by the NHiS Commissioning Excellence and the Multiple Sclerosis (MS) Trust, highlights the healthcare costs…
Articles by Margarida Azevedo, MSc
ForuMS Gives MS Clinicians an Online Link to Latest Research
ForuMS is a new interactive and online “journal club” where clinicians treating multiple sclerosis (MS) patients or involved in research can discuss…
Hemispherx Biopharma and myTomorrows Collaborate to Provide South American MS Patients with Interferon Therapy
MyTomorrows, a company that provides information and facilitates requests regarding clinical trials, diagnostic tests and medicines through its internet-based…
Biogen’s TYSABRI for Secondary Progressive MS Fails to Meet Phase 3 Trial Endpoints
Biogen Inc. recently reported that the Phase 3 ASCEND clinical trial study testing TYSABRI efficacy in patients with secondary…
Study Identifies Blood Coagulation Protein Fibrinogen as Cause of Brain Autoimmunity
Researchers from the Gladstone Institutes have shown in a new study that fibrinogen, an important blood coagulation protein, can induce…
Promising Data on ZINBRYTA (Daclizumab High-Yield Process) Compared to Interferon Beta-1a in RRMS, ECTRIMS 2015
Lead scientists representing Biogen and AbbVie presented new data on clinical results from the Phase 3 study DECIDE on the…